Description
Muco Rhinathiol® is a carbocisteine-based medicine. Reduces persistent phlegm in respiratory conditions associated with a persistent wet cough.
Do not use Muco Rhinathiol in cases of dry cough or irritative cough.
Suggested for the treatment of respiratory tract disorders accompanied by mucus abnormalities in pneumology and certain ENT disorders, such as chronic seromucous otitis and chronic sinusitis.
Adults and children > 15 years
45 to 60 ml per day, divided into 3 doses
Carbocisteine 750 mg per 15 ml.
List of excipients:
- Methylparahydroxybenzoate
- Sucrose
- Caramel powder
- Aromatic elixir
- Essence of cinnamon
- Sodium hydroxide
- Purified water.
Carbocisteine has experimental mucoregulating properties on pathological viscous secretions, which appear in the event of respiratory tract mucosal disorders:
Clinically, carbocisteine has an in-vivo mucolytic effect, confirmed by :
- improvement in the rheological qualities of respiratory mucus (viscosity, elasticity, filance),
- normalisation of mucociliary transport through action on mucus and mucosa,
- reducing airway resistance,
These properties make carbocistein a mucoprotector for the respiratory tract:
- protection of the ciliated epithelium,
- reduction in mucociliary hyperplasia.
Carbocistein also promotes the penetration of certain antibiotics into the secretions of the respiratory mucosa (amoxicillin, bacampicillin, a combination of cefuroxim, mezlocillin, ampicillin and cefotaxin).
Carbocistein improves the mobility of pathological secretions, making expectoration easier and clearing the airways.
